Skip to content
Trial Eligibility
Menu

Visual Hallucinations in Lewy Body Diseases

NCT07849413

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this basic experimental study involving humans (BESH) protocol is to improve the understanding of neural mechanisms underlying visual hallucinations in Lewy Body diseases to inform future treatment developments.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lewy Body Disease
  • Lewy Body Dementia
  • Parkinson Disease
  • Parkinson Disease Dementia
  • Visual Hallucinations

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 90 years
Sex
All
Healthy volunteers
Accepted
Sponsor
NYU Langone Health
Last updated on ClinicalTrials.gov
September 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • NYU Langone Health · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.